{"bill":{"bill_id":1276487,"change_hash":"d9e73f4458e9beadefe16d2f5fc76a31","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/HB4629\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/house-bill\/4629\/all-info","completed":0,"status":1,"status_date":"2019-10-08","progress":[{"date":"2019-10-08","event":1},{"date":"2019-10-08","event":9},{"date":"2019-10-08","event":9},{"date":"2019-10-08","event":9},{"date":"2019-10-09","event":9}],"state":"US","state_id":52,"bill_number":"HB4629","bill_type":"B","bill_type_id":"1","body":"H","body_id":114,"current_body":"H","current_body_id":114,"title":"Star Rating for Biosimilars Act","description":"Requires the Centers for Medicare & Medicaid Services (CMS) to establish quality measures regarding biosimilar biological products under the five-star performance rating system for Medicare Advantage plans. The measures must assess the level of access that plans provide to covered biosimilars, including with respect to formularies, cost-sharing, and utilization management. The CMS must also incorporate such measures into similar rating systems for plans under the Medicare prescription drug benefit.","pending_committee_id":0,"committee":[],"referrals":[{"date":"2019-10-08","committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"},{"date":"2019-10-09","committee_id":2355,"chamber":"H","chamber_id":114,"name":"Subcommittee on Health"}],"history":[{"date":"2019-10-08","action":"Introduced in House","chamber":"H","chamber_id":114,"importance":0},{"date":"2019-10-08","action":"Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.","chamber":"H","chamber_id":114,"importance":1},{"date":"2019-10-08","action":"Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.","chamber":"H","chamber_id":114,"importance":1},{"date":"2019-10-08","action":"Referred to the Subcommittee on Health.","chamber":"H","chamber_id":114,"importance":1},{"date":"2019-10-09","action":"Referred to the Subcommittee on Health.","chamber":"H","chamber_id":114,"importance":1},{"date":"2019-10-18","action":"Sponsor introductory remarks on measure. (CR H8232)","chamber":"H","chamber_id":114,"importance":0}],"sponsors":[{"people_id":9167,"person_hash":"aaq2jux5","party_id":"1","state_id":52,"party":"D","role_id":1,"role":"Rep","name":"Paul Tonko","first_name":"Paul","middle_name":"D.","last_name":"Tonko","suffix":"","nickname":"","district":"HD-NY-20","ftm_eid":4469600,"votesmart_id":4403,"opensecrets_id":"N00030196","knowwho_pid":197757,"ballotpedia":"Paul_Tonko","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":11053,"person_hash":"6o3k1bdd","party_id":"2","state_id":52,"party":"R","role_id":1,"role":"Rep","name":"Bob Gibbs","first_name":"Bob","middle_name":"","last_name":"Gibbs","suffix":"","nickname":"","district":"HD-OH-7","ftm_eid":3104545,"votesmart_id":45466,"opensecrets_id":"N00031128","knowwho_pid":212534,"ballotpedia":"Bob_Gibbs","sponsor_type_id":2,"sponsor_order":2,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":8,"type":"Related","sast_bill_number":"SB2543","sast_bill_id":1275544},{"type_id":8,"type":"Related","sast_bill_number":"HB3","sast_bill_id":1275160},{"type_id":8,"type":"Related","sast_bill_number":"SB4199","sast_bill_id":1372542}],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13206,"subject_name":"Health care costs and insurance"},{"subject_id":13207,"subject_name":"Health care coverage and access"},{"subject_id":13208,"subject_name":"Health care quality"},{"subject_id":13212,"subject_name":"Health programs administration and funding"},{"subject_id":13242,"subject_name":"Medicare"},{"subject_id":13258,"subject_name":"Performance measurement"},{"subject_id":13490,"subject_name":"Prescription drugs"}],"texts":[{"doc_id":2056305,"date":"2019-10-09","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/HB4629\/id\/2056305","state_link":"https:\/\/www.congress.gov\/116\/bills\/hr4629\/BILLS-116hr4629ih.pdf","text_size":345913,"text_hash":"66e6a818ee6686e0190ef3882b557836"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}